WAM
SNTI icon

Wolverine Asset Management’s Senti Biosciences Holdings SNTI Stock Holding History

Wolverine Asset Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-80
Closed -$220 – 1782
2024
Q2 		$220 Hold
80
– – ﹤0.01% 1613
2024
Q1 		$301 Hold
80
– – ﹤0.01% 1591
2023
Q4 		$528 Hold
80
– – ﹤0.01% 1653
2023
Q3 		$330 Hold
80
– – ﹤0.01% 1773
2023
Q2 		$501 Hold
80
– – ﹤0.01% 1685
2023
Q1 		$944 Hold
80
– – ﹤0.01% 1716
2022
Q4 		$1.13K Hold
80
– – ﹤0.01% 1929
2022
Q3 		$1K Hold
80
– – ﹤0.01% 2321
2022
Q2 		$1K Buy
+80
New +$6.43K ﹤0.01% 2284

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Wolverine Asset Management's SNTI Position: Q3 2024 in Review

Wolverine Asset Management sold out of Senti Biosciences Holdings (SNTI) in Q3 2024, closing a stake of 80 shares — an estimated $220 sold.

Wolverine Asset Management first reported a position in SNTI in Q2 2022 and held it in 9 quarters. The position peaked at $1.13K in Q4 2022. 14 funds tracked by Wall St. Rank hold SNTI as of Q3 2024.

  • Wolverine Asset Management reported no remaining Senti Biosciences Holdings position as of Q3 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 80 Senti Biosciences Holdings shares in Q3 2024, an estimated $220.
  • Wolverine Asset Management first reported a position in Senti Biosciences Holdings in Q2 2022 and held it in 9 quarters.
  • Wolverine Asset Management's Senti Biosciences Holdings position peaked at $1.13K in Q4 2022.
  • 14 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2024.

Based on Wolverine Asset Management's 13F filing for Q3 2024, filed 4 Nov 2024.